Which health goal is driving this decision?
Ask whether the main goal is weight management or another condition relevant to the proposed product’s approved uses. Current Zepbound and Wegovy labels have different indication details, and their formats are not identical.[source][source]
The largest average weight change in one trial is not the only possible clinical consideration. The clinician should explain why the proposed treatment fits the actual goal.
What history changes the options?
Bring a complete medication list and relevant history, including prior reactions, gastrointestinal conditions, pregnancy plans and family history of medullary thyroid carcinoma or MEN 2. The current labels contain important contraindications and precautions.[source][source]
Also mention planned procedures involving anesthesia or deep sedation. Do not assume the prescribing professional already has information recorded at another service.
What exactly would be prescribed?
Ask for the brand or compounded status, formulation and delivery presentation. A pill, single-dose pen, KwikPen and vial have different practical instructions. If compounding is proposed, ask why and which pharmacy would dispense it.[source]
Request a clear explanation of the prescription and label. This site does not provide a dose-conversion table or recommend switching medicines.
How will treatment be reviewed?
Establish what follow-up is included, who answers medication questions and which symptoms require prompt attention. Ask how the clinician evaluates response and tolerability and what might lead to a change in plan.
A provider’s broad support promise is not evidence of a measured response time. Make the actual contact route part of the decision.
Can the plan be sustained?
Discuss complete recurring cost, coverage uncertainty and what happens if the service or medicine becomes unavailable. Ask how a transition would be managed clinically.
The cost guide helps organize the financial details. The aim is an understandable treatment relationship, not simply an order placed from the first card on a website.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Zepbound prescribing informationManufacturer prescribing information, warnings and approved uses · Checked October 8, 2026
- Wegovy prescribing informationManufacturer labeling; formulation-specific directions and safety information · Checked October 8, 2026
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags · Checked October 10, 2026